We bring ideas to life
The University of Auckland’s new Innovation Institute China (UAIIC) will provide unprecedented access to an extensive range of networks, research and funding opportunities in China.
The University of Auckland’s knowledge transfer company, UniServices, has established the institute in the Chinese city of Hangzhou. It is due to formally open in the first quarter of 2017 and will focus on collaboration.
The Innovation Institute will allow the University of Auckland, UniServices and its partners to:
UniServices and the University of Auckland are partnering with an American drug development company to launch a biotech start-up that will research novel cancer vaccines.
The new start-up, SapVax was formed by scientists from the University of Auckland and BioMotiv, an accelerator company in Cleveland, Ohio, that is part of a $300 million initiative for advancing medicine called The Harrington Project for Discovery & Development.
SapVax will develop a suite of first-in-class cancer vaccines based on a novel peptide platform technology.